In last trading session, Mira Pharmaceuticals Inc (NASDAQ:MIRA) saw 0.36 million shares changing hands with its beta currently measuring 2.09. Company’s recent per share price level of $1.26 trading at -$0.07 or -5.26% at ring of the bell on the day assigns it a market valuation of $20.87M. That closing price of MIRA’s stock is at a discount of -297.62% from its 52-week high price of $5.01 and is indicating a premium of 59.52% from its 52-week low price of $0.51. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.57 million shares which gives us an average trading volume of 1.45 million if we extend that period to 3-months.
Mira Pharmaceuticals Inc (NASDAQ:MIRA) trade information
Upright in the red during last session for losing -5.26%, in the last five days MIRA remained trading in the green while hitting it’s week-highest on Tuesday, 01/07/25 when the stock touched $1.26 price level, adding 16.0% to its value on the day. Mira Pharmaceuticals Inc’s shares saw a change of 10.53% in year-to-date performance and have moved 9.57% in past 5-day. Mira Pharmaceuticals Inc (NASDAQ:MIRA) showed a performance of 2.44% in past 30-days. Number of shares sold short was 1.26 million shares which calculate 0.47 days to cover the short interests.
Mira Pharmaceuticals Inc (MIRA) estimates and forecasts
Statistics highlight that Mira Pharmaceuticals Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company added 109.97% of value to its shares in past 6 months, showing an annual growth rate of 6.25% while that of industry is 16.50. Apart from that, the company came raising its revenue forecast for fiscal year 2025.
Mira Pharmaceuticals Inc (NASDAQ:MIRA)’s Major holders
Insiders are in possession of 27.21% of company’s total shares while institution are holding 5.96 percent of that, with stock having share float percentage of 8.18%. Investors also watch the number of corporate investors in a company very closely, which is 5.96% institutions for Mira Pharmaceuticals Inc that are currently holding shares of the company.
On the other hand, Fidelity Extended Market Index Fund and Fidelity Total Market Index Fund are the top two Mutual Funds which own company’s shares. As of Nov 30, 2024 , the former fund manager was holding 59.98 shares of worth $75573.0 or 0.36% of the total outstanding shares. The later fund manager was in possession of 21.89 shares on Nov 30, 2024 , making its stake of worth around $27585.0 in the company or a holder of 0.13% of company’s stock.
